Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
- PMID: 27807816
- PMCID: PMC5126200
- DOI: 10.1007/s12325-016-0436-0
Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
Abstract
Introduction: Recent studies have indicated that patients are showing increased interest in playing a larger role in making decisions regarding their medical treatment. Inflammatory bowel disease (IBD) is a chronic disease that manifests either as Crohn's disease (CD) or ulcerative colitis (UC). IBD treatment is multifaceted and dependent on patient-specific factors. The selection of treatment options is mostly driven by physicians, and it is unclear to what degree patients are involved in shared decision-making (SDM). The objective of the current study is to assess preferences among Japanese patients with IBD in regard to SDM during their treatment for IBD.
Methods: A nationwide web-based survey was performed in Japan during February 2016. The patients were asked for their basic clinical characteristics, socioeconomic status, medical history, treatment details, and preferences regarding SDM in IBD treatment. Differences were analyzed by chi-square, t tests, a multiple regression analysis, and ordered logistic regression analysis.
Results: In response to the screening survey, a total of 1068 Japanese nationals met the inclusion criteria for this study of being patients diagnosed with IBD who are currently receiving treatment. Of these, 235 had CD and 800 UC; 33 were not specified. Overall, the majority of these patients felt that SDM was very important. Furthermore, interest in SDM was strongly associated with certain disease comorbidities, surgical history, and current treatment, although there were some differences in the results between CD and UC.
Conclusion: The present study found that the majority of IBD patients in Japan wanted to have a role in their treatment plan. The results indicate that the patient's preference in regard to SDM was driven by their perception of the severity or progression of their disease.
Funding: Janssen Pharmaceuticals.
Keywords: Gastroenterology; Inflammatory bowel disease; Japan; Patient preferences; Shared decision making.
Figures


Similar articles
-
Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.Am J Gastroenterol. 2018 Jan;113(1):58-71. doi: 10.1038/ajg.2017.470. Epub 2017 Dec 5. Am J Gastroenterol. 2018. PMID: 29206816
-
Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.J Gastroenterol. 2017 May;52(5):555-567. doi: 10.1007/s00535-016-1241-x. Epub 2016 Jul 28. J Gastroenterol. 2017. PMID: 27470433 Free PMC article.
-
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.Inflamm Bowel Dis. 2024 Dec 5;30(12):2380-2394. doi: 10.1093/ibd/izae015. Inflamm Bowel Dis. 2024. PMID: 38503480 Free PMC article.
-
Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review.Patient. 2018 Jun;11(3):271-284. doi: 10.1007/s40271-017-0294-0. Patient. 2018. PMID: 29313266 Review.
-
Medical Management of Aggressive Inflammatory Bowel Disease: When Is the Time to Cut Your (and the Patient's) Losses?J Laparoendosc Adv Surg Tech A. 2021 Aug;31(8):905-910. doi: 10.1089/lap.2021.0338. Epub 2021 Jun 25. J Laparoendosc Adv Surg Tech A. 2021. PMID: 34171979 Review.
Cited by
-
Shared decision-making in the management of patients with inflammatory bowel disease.World J Gastroenterol. 2022 Jul 14;28(26):3092-3100. doi: 10.3748/wjg.v28.i26.3092. World J Gastroenterol. 2022. PMID: 36051346 Free PMC article. Review.
-
Ileostomy or ileal pouch-anal anastomosis for ulcerative colitis: patient participation and decisional needs.BMC Gastroenterol. 2021 Sep 19;21(1):347. doi: 10.1186/s12876-021-01916-0. BMC Gastroenterol. 2021. PMID: 34538236 Free PMC article.
-
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis.Intest Res. 2021 Oct;19(4):448-460. doi: 10.5217/ir.2020.00026. Epub 2020 Aug 18. Intest Res. 2021. PMID: 32806876 Free PMC article.
-
Factors Influencing Decision-Making Preferences Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study in China.Patient Prefer Adherence. 2025 Apr 12;19:1047-1057. doi: 10.2147/PPA.S517510. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40255863 Free PMC article.
-
Shared Decision Making in Gastroenterology: Challenges and Opportunities.Mayo Clin Proc Innov Qual Outcomes. 2020 Mar 9;4(2):183-189. doi: 10.1016/j.mayocpiqo.2019.11.003. eCollection 2020 Apr. Mayo Clin Proc Innov Qual Outcomes. 2020. PMID: 32280929 Free PMC article. Review.
References
-
- Cella D, Nichol MB, Eton D, Nelson JB, Mulani P. Estimating clinically meaningful changes for the functional assessment of cancer therapy—prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health J Int Soc Pharmacoecon Outcomes Res. 2009;12(1):124–129. doi: 10.1111/j.1524-4733.2008.00409.x. - DOI - PubMed
-
- Degner LFSJ, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29(3):21–43. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous